MILLENNIUM HEALTH LLC

COGENDX

Medical testing services for diagnostic or treatment purposes marketed and sold to healthcare providers and insurers, namely, third-party testing of patient oral fluids, skin specimens, or wound specimens; medical services, namely, DNA testing services to evaluate patient treatment plans and improve clinical outcomes and patient safety; pharmacogenetic testing services for detection or treatment purposes to predict a how a patient's genetic makeup may impact the patient's response to specific medications; medical testing service for detection of infectious agents and identification of appropriate antimicrobial therapy to improve clinical outcomes; medical testing services permitting clinicians to tailor surgical and anesthesia plans to each patient to optimize surgery outcomes; medical testing services for wound care;

MEDINTEL

MED INTEL;Medical testing services for detection, diagnostic or treatment purposes marketed and sold to healthcare providers and insurers, namely, third-party testing of patient urine, blood, and/or oral fluids, and skin or wound specimens; medical services, namely, medication monitoring and drug detection services to evaluate patient treatment plans to improve clinical outcomes and patient safety; drug use testing services, namely, testing patient urine, blood and/or oral fluid for medication or drug abuse and/or compliance with patient prescriptions; medical pharmacogenetic testing services for detection or treatment purposes that predict how a patient's genetic makeup may impact the patient's response to specific medications; medical testing services for detection of infectious disease; medical testing services for identification of appropriate antimicrobial therapy to improve clinical outcomes;

MEDINTEL

The mark consists of the literal element MEDINTEL with three dashed lines above the literal element arranged in a sawtooth pattern centered on the dot of the I in MEDINTEL. Each dashed line terminates with a dot.;MEDICAL INTELLIGENCE;Color is not claimed as a feature of the mark.;Medical testing services; medical testing services for detection, diagnostic or treatment purposes marketed and sold to healthcare providers and insurers, namely, third-party testing of patient urine, blood, and/or oral fluids, and skin or wound specimens; medical services, namely, medication monitoring and drug detection services to evaluate patient treatment plans to improve clinical outcomes and patient safety; drug use testing services, namely, testing patient urine, blood and/or oral fluid for medication or drug abuse and/or compliance with patient prescriptions; medical pharmacogenetic testing services for detection or treatment purposes that predict how a patient's genetic makeup may impact the patient's response to specific medications; medical testing services for detection of infectious disease; medical testing services for identification of appropriate antimicrobial therapy to improve clinical outcomes;